Grants and Contributions

Install solar power in the therapy center and build a second-floor treatment area

This project will involve the development of a proprietary lipid nanoparticle (LNP)-mRNA technology for the safe and effective delivery of mRNA encoding the hepatokine Fibroblast Growth Factor 21 (FGF21) as a hepatic gene therapy to promote weight loss in a diet-induced obesity models.

Such a predictor would enable us to identify those people at greatest risk of developing the disease earlier, when disease modifying therapies are deemed most effective, reducing the need for long-term care and increasing quality of life.

To create value-added opportunities for the training, education, and professional development of graduate students, to ensure continued improvement of asthma treatment therapies and progress towards finding a cure for asthma.

To create value-added opportunities for the training, education, and professional development of graduate students, to ensure continued improvement of asthma treatment therapies and progress towards finding a cure for asthma.

Older adults experience barriers to achieving full postoperative potential during conventional, unsupervised in-home therapy, underscoring the need for innovative rehabilitation tools after total joint replacement (TJR).

Non-pharmacological interventions centered around lifestyle modifications constitute promising approaches to delay the onset or progression of neurodegenerative diseases impacting cognition. An important challenge for the implementation of such interventions is the ability to deliver them in an accessible PAGE 4 and ecological context. To address these challenges, mobile technologies have been increasingly used over the past decade to provide health-related assessments or interventions for older adults in their own living environment. The extent to which mobile assessments and interventions can be integrated to improve health outcomes deserves further investigation. In this project, we will investigate the feasibility and benefits of developing and using a digital phenotyping approach based on remote assessments of sleep and cognition in older adults in the community. We will then explore whether such digital phenotyping may improve the outcomes of a web-based intervention that was developed to promote better sleep and brain health in older adults. This phenotyping approach will allow to collect information on lifestyle factors such as sleep, passively using sensors and actively via short surveys and tasks. Using it, the CRIUGM will run several user-based studies and validate its feasibility with older adults. The integration of measures from the phenotyping approach into the web-based intervention platform is to be used to improve an online sleep-related intervention by tailoring it to the individual’s needs. In addition, it is expected that this integration between remote assessments and intervention will also improve personalized feedback to the user during the intervention, and therefore improve acceptability, engagement, and adherence of older adults to the intervention.

This project will allow the firm, with the recently-hired clinical relations manager, marketing associate and marketing COOP, to develop and experiment with new B2B2C commercial deployment and fulfilment processes to increase market penetration of the Tenzr system for Physical Therapy.

There are currently no existing therapies that direct remove these deposits from organs.

The approval of chimeric antigen receptor T-cell (CAR-T) therapies has been a major breakthrough for patients with relapsed or refractory blood cancers. However, CAR-T cells are highly complex, live cell therapies, and it has proven difficult to predict CAR-T cell potency.